867
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comparative abilities of Candida glabrata and Candida albicans to colonize and translocate from the intestinal tract of antibiotic-treated mice

, , , &
Pages 129-137 | Received 22 Apr 2005, Published online: 11 Jul 2009

References

  • Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three year analysis. Clin Infect Dis 1999; 29: 239–44
  • Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from laboratory to the bedside. Clin Infect Dis 1996; 22(Suppl 2)S73–S88
  • White MH. Epidemiology of invasive candidiasis: recent progress and current controversies. Int J Infect Dis 1997; 1(Suppl 1)S7–S10
  • Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, et al. Epidemiology, diagnosis, and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24: 206–16
  • Rangel-Frausto, MS, Wiblin, T, Blumberg, HM, Saiman, L, Patterson, J, Rinaldi, M, et al. and the, NEMIS Study Group. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1995;29:253–8.
  • Fidel PL, Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999; 12: 80–96
  • Fidel, PL, Jr. Section IV immunity. In:. RA Calderone, ed., Candida and candidiasis. Washington, DC: American Society for Microbiology Press, 2002:179–256.
  • Csank C, Haynes K. Candida glabrata displays pseudohyphal growth. FEMS Microbiol Lett 2000; 189: 115–20
  • Pfaller, NA, Jones, RN, Sader, HS, Messer, SA, Houston, MA, Coffman, S, et al. and the, Sentry Participant Group. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 2000;44:747–51.
  • Gumbo T, Isada CM, Hall G, Karafa T, Gordon SM. Candida glabrata fungemia: clinical features of 139 patients. Medicine 1999; 78: 220–7
  • Vazquez JA, Dembry LM, Sanchez V, Vazquez MA, Sobel JD, Dmuchowsk C, et al. Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol 1998; 36: 421–6
  • Brieland J, Essig D, Jackson C, Frank D, Loebenberg D, Menzel F, et al. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun 2001; 69: 5046–55
  • Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 2001; 47: 308–13
  • Hedderwick SA, Lyons MJ, Liu M, Vazquez JA, Kauffman CA. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000; 19: 663–70
  • Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993; 134: 717–28
  • Lo H-J, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997; 90: 939–49
  • Kim AS, Garni RM, Bendel CM, Wells CL. Hypoxia and extraintestinal dissemination of Candida albicans yeast forms. Shock 2003; 19: 257–62
  • Riggle PR, Andrutis KA, Chen X, Tzipori SR, Kumamoto CA. Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture. Infect Immun 1999; 67: 3649–52
  • Bendel CM, Hess DJ, Garni RM, Henry-Stanley M, Wells CL. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med 2003; 31: 501–7
  • Wells CL, Feltis BA, Hanson DF, Jechorek RP, Erlandsen SL. Oral infectivity and bacterial interactions with mononuclear phagocytes. J Med Microbiol 1993; 38: 345–53
  • Henry-Stanley MJ, Hess DJ, Erickson EA, Garni RM, Wells CL. Effect of lipopolysaccharide on virulence of intestinal Candida albicans. J Surg Res 2003; 113: 42–9
  • Bernhardt HM, Knoke M. Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 1997; 222: 102–6
  • Kandel JS, Stern TA. Killer phenomenon in pathogenic yeast. Antimicrob Agents Chemother 1979; 15: 568–71
  • Kirkpatrick ER, Lopez-Ribot JL, Mcatee RK, Patterson TF. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol 2000; 38: 902–4
  • Hummel RP, Maley MP, Miskell PW, Altemeier WA. Suppression of Candida albicans by Escherichia coli. J Trauma 1975; 15: 413–18